Zhejiang Dayang Biotech Group Co (003017) — Cash Flow Quality Index
Zhejiang Dayang Biotech Group Co (003017) has a Cash Flow Quality Index of 0.02x as of September 2025. Operating cash flow of CN¥638.25K is below net income of CN¥29.53 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore debt repayment capacity of Zhejiang Dayang Biotech Group Co to assess how comfortably operating cash covers total debt obligations.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Zhejiang Dayang Biotech Group Co Cash Flow Quality Index (2013–2025)
Historical Cash Flow Quality Index for Zhejiang Dayang Biotech Group Co across 13 annual periods. Values consistently above 1.0x indicate high-quality earnings. For the full cash flow conversion analysis, see cash efficiency ratio of Zhejiang Dayang Biotech Group Co.
Annual Cash Flow Quality Index for Zhejiang Dayang Biotech Group Co (2013–2025)
Year-by-year earnings quality comparison for Zhejiang Dayang Biotech Group Co.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.60x | CN¥160.11 Million | CN¥99.85 Million | ▲ +54.4% |
| 2024 | 1.04x | CN¥66.19 Million | CN¥63.74 Million | ▼ -71.5% |
| 2023 | 3.65x | CN¥182.42 Million | CN¥50.01 Million | ▲ +220.5% |
| 2022 | 1.14x | CN¥91.89 Million | CN¥80.73 Million | ▲ +326.7% |
| 2021 | -0.50x | CN¥-35.16 Million | CN¥70.01 Million | ▼ -140.9% |
| 2020 | 1.23x | CN¥112.49 Million | CN¥91.61 Million | ▼ -13.7% |
| 2019 | 1.42x | CN¥113.09 Million | CN¥79.50 Million | ▲ +159.7% |
| 2018 | 0.55x | CN¥38.77 Million | CN¥70.80 Million | ▼ -43.4% |
| 2017 | 0.97x | CN¥48.64 Million | CN¥50.25 Million | ▼ -67.0% |
| 2016 | 2.93x | CN¥84.63 Million | CN¥28.85 Million | ▲ +41.8% |
| 2015 | 2.07x | CN¥48.95 Million | CN¥23.67 Million | ▲ +0.6% |
| 2014 | 2.06x | CN¥57.73 Million | CN¥28.07 Million | ▼ -40.9% |
| 2013 | 3.48x | CN¥91.64 Million | CN¥26.32 Million | — |